FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2418113816> ?p ?o ?g. }

• W2418113816 endingPage "6" @default.
• W2418113816 startingPage "1994" @default.
• W2418113816 abstract "To evaluate therapeutic effectiveness and safety of botulinum toxin type A in the treatment of idiopathic trigeminal neuralgia in patients older than 70 years.The total 64 patents were involved from neurology clinic and inpatient department from Aug 2008 to Sep 2013. They were divided into two groups according to the age (older than 70 years versus younger than 60 years. The therapeutic dose, safety, effectiveness were compared between two groups. Visual analog scores were employed to measure the degree of pain.The mean dosage was (88 ± 30) U in the group aged above 70 years old, and (72 ± 33) U in the group aged below 60 years old respectively. There was no significant difference of dosage between the two groups. The average visual analog score of all patients was (7.7 ± 2.2) before the treatment and decreased to (4.4 ± 2.9) one month after the treatment. To be precise, the average visual analog score of the group aged above 70 years old was (8.2 ± 1.9) before and (4.5 ± 3.2) after the treatment, and the visual analog score of the group aged below 60 years old was (7.2 ± 2.4) before and (4.4 ± 2.5) after the treatment. The effect of botulinum toxin type A in the treatment of idiopathic trigeminal neuralgia was considered statistically significant. The D-value of visual analog score in the elderly group was (3.5 ± 3.6), and (2.8 ± 3.5) in the younger group. There was no significant difference in the D-value between the two groups. Five patients had transient minor side effects in the former group and two patients had transient minor side effects in latter group. There was no significant difference in the incidence rate of side effects between the two groups (P > 0.05).Botulinum toxin type A is safe and effective in the treatment of idiopathic trigeminal neuralgia for the patients older than 70 years and the dosages of it are approximate to the patients under 60 years old." @default.
• W2418113816 created "2016-06-24" @default.
• W2418113816 creator A5011117741 @default.
• W2418113816 creator A5043353234 @default.
• W2418113816 creator A5071336475 @default.
• W2418113816 creator A5076114328 @default.
• W2418113816 creator A5077265169 @default.
• W2418113816 creator A5081643835 @default.
• W2418113816 date "2015-07-07" @default.
• W2418113816 modified "2023-10-18" @default.
• W2418113816 title "[Evaluation of therapeutic effectiveness and safety of botulinum toxin type A in the treatment of idiopathic trigeminal neuralgia in patients older than 70 years]." @default.
• W2418113816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26710807" @default.
• W2418113816 hasPublicationYear "2015" @default.
• W2418113816 type Work @default.
• W2418113816 sameAs 2418113816 @default.
• W2418113816 citedByCount "2" @default.
• W2418113816 countsByYear W24181138162017 @default.
• W2418113816 countsByYear W24181138162020 @default.
• W2418113816 crossrefType "journal-article" @default.
• W2418113816 hasAuthorship W2418113816A5011117741 @default.
• W2418113816 hasAuthorship W2418113816A5043353234 @default.
• W2418113816 hasAuthorship W2418113816A5071336475 @default.
• W2418113816 hasAuthorship W2418113816A5076114328 @default.
• W2418113816 hasAuthorship W2418113816A5077265169 @default.
• W2418113816 hasAuthorship W2418113816A5081643835 @default.
• W2418113816 hasConcept C102652120 @default.
• W2418113816 hasConcept C118552586 @default.
• W2418113816 hasConcept C126322002 @default.
• W2418113816 hasConcept C141071460 @default.
• W2418113816 hasConcept C14184104 @default.
• W2418113816 hasConcept C16568411 @default.
• W2418113816 hasConcept C2777478456 @default.
• W2418113816 hasConcept C2780355897 @default.
• W2418113816 hasConcept C3018023364 @default.
• W2418113816 hasConcept C42219234 @default.
• W2418113816 hasConcept C71924100 @default.
• W2418113816 hasConceptScore W2418113816C102652120 @default.
• W2418113816 hasConceptScore W2418113816C118552586 @default.
• W2418113816 hasConceptScore W2418113816C126322002 @default.
• W2418113816 hasConceptScore W2418113816C141071460 @default.
• W2418113816 hasConceptScore W2418113816C14184104 @default.
• W2418113816 hasConceptScore W2418113816C16568411 @default.
• W2418113816 hasConceptScore W2418113816C2777478456 @default.
• W2418113816 hasConceptScore W2418113816C2780355897 @default.
• W2418113816 hasConceptScore W2418113816C3018023364 @default.
• W2418113816 hasConceptScore W2418113816C42219234 @default.
• W2418113816 hasConceptScore W2418113816C71924100 @default.
• W2418113816 hasIssue "25" @default.
• W2418113816 hasLocation W24181138161 @default.
• W2418113816 hasOpenAccess W2418113816 @default.
• W2418113816 hasPrimaryLocation W24181138161 @default.
• W2418113816 hasRelatedWork W1559177906 @default.
• W2418113816 hasRelatedWork W2035748022 @default.
• W2418113816 hasRelatedWork W2135244205 @default.
• W2418113816 hasRelatedWork W2140558584 @default.
• W2418113816 hasRelatedWork W2366282872 @default.
• W2418113816 hasRelatedWork W2404719899 @default.
• W2418113816 hasRelatedWork W2417789037 @default.
• W2418113816 hasRelatedWork W2418113816 @default.
• W2418113816 hasRelatedWork W2972037298 @default.
• W2418113816 hasRelatedWork W3198346145 @default.
• W2418113816 hasVolume "95" @default.
• W2418113816 isParatext "false" @default.
• W2418113816 isRetracted "false" @default.
• W2418113816 magId "2418113816" @default.
• W2418113816 workType "article" @default.